Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics
The low water solubility of pharmacoactive molecules limits their pharmacological potential,
but the solubility parameter cannot compromise, and so different approaches are employed …
but the solubility parameter cannot compromise, and so different approaches are employed …
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …
Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs
P Tran, YC Pyo, DH Kim, SE Lee, JK Kim, JS Park - Pharmaceutics, 2019 - mdpi.com
Approximately 40% of new chemical entities (NCEs), including anticancer drugs, have been
reported as poorly water-soluble compounds. Anticancer drugs are classified into biologic …
reported as poorly water-soluble compounds. Anticancer drugs are classified into biologic …
Nanotechnology for angiogenesis: opportunities and challenges
S Kargozar, F Baino, S Hamzehlou… - Chemical Society …, 2020 - pubs.rsc.org
Angiogenesis plays a critical role within the human body, from the early stages of life (ie,
embryonic development) to life-threatening diseases (eg, cancer, heart attack, stroke, wound …
embryonic development) to life-threatening diseases (eg, cancer, heart attack, stroke, wound …
Pharmaceutical dispersion techniques for dissolution and bioavailability enhancement of poorly water-soluble drugs
X Zhang, H Xing, Y Zhao, Z Ma - Pharmaceutics, 2018 - mdpi.com
Over the past decades, a large number of drugs as well as drug candidates with poor
dissolution characteristics have been witnessed, which invokes great interest in enabling …
dissolution characteristics have been witnessed, which invokes great interest in enabling …
Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor
activity against various cancer cells. These chemotherapeutic agents suffer from a number of …
activity against various cancer cells. These chemotherapeutic agents suffer from a number of …
Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends
The oral delivery of cancer chemotherapeutic drugs is challenging due to low bioavailability,
gastrointestinal side effects, first-pass metabolism and P-glycoprotein efflux pumps. Thus …
gastrointestinal side effects, first-pass metabolism and P-glycoprotein efflux pumps. Thus …
Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs
P Tran, JS Park - Journal of Pharmaceutical Investigation, 2021 - Springer
Background The oral route is the most popular route for the clinical administration of drugs to
treat various diseases. Before a drug is absorbed into the blood circulation, it must undergo …
treat various diseases. Before a drug is absorbed into the blood circulation, it must undergo …
Synthesis of PAMAM dendrimers anchored to WS2 nano-sheets for controlled delivery of docetaxel: Design, characterization and in vitro drug release
M Mahdavijalal, HA Panahi, E Moniri - Journal of Drug Delivery Science …, 2023 - Elsevier
The oral delivery of anti-cancer agents is typically challenging due to low bioavailability and
significant gastrointestinal side effects of drugs. Docetaxel is a lipophilic anti-cancer agent …
significant gastrointestinal side effects of drugs. Docetaxel is a lipophilic anti-cancer agent …
[HTML][HTML] Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self …
This study aimed to develop and optimize a self-nanoemulsifying drug delivery system
(SNEDDS) of bosentan (BOS) to solve its poor oral bioavailability due to low water solubility …
(SNEDDS) of bosentan (BOS) to solve its poor oral bioavailability due to low water solubility …